Mitochondrial Genomics and Effects of Cocaine on T cells during HIV-Infection

HIV 感染期间线粒体基因组学和可卡因对 T 细胞的影响

基本信息

  • 批准号:
    7931761
  • 负责人:
  • 金额:
    $ 15.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-15 至 2012-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cocaine is a common drug of abuse among HIV-infected persons, and its use has been independently associated with poorer clinical outcomes, including more rapid HIV disease progression. In addition to indirect effects on psychosocial stability that limit adherence to medical care and HIV treatments, data also suggest direct effects of cocaine on CD4+ and CD8+ T cell function and enhanced HIV replication that may contribute to accelerated HIV disease. Cocaine has been shown to have adverse effects on cells in multiple in vitro and animal model systems- primarily through mitochondrial induction of the apoptotic pathway. Given the primary role of mitochondria-mediated apoptosis in CD4+ T cell depletion during HIV-infection, we suspect that the untoward effects of cocaine on CD4+ T cells and HIV disease progression are mediated by mitochondria- induced apoptosis, though data directly linking cocaine exposure to enhanced CD4+ T cell apoptosis are lacking. Mitochondrial DNA (mtDNA) is present in each mitochondrion, encodes protein subunits required for cellular oxidative phosphorylation, and is a primary mediator of oxidative stress, antioxidant capacity, and induction of apoptosis in response to cellular damage. Mitochondrial DNA haplogroups are based on inherited polymorphic variation, denote maternal ancestry and human migrations, and have been associated with risk of degenerative and metabolic diseases, and longevity. Our group has devoted considerable effort to understanding the relevance of mtDNA variation in HIV treatment complications, and a recent study by other investigators identified associations between haplogroups and HIV disease progression in cohorts of persons of European descent. The goals of the proposed pilot studies are to better understand interactions between drug use and altered HIV progression and AIDS pathogenesis through novel analyses of the effects of cocaine use on CD4+ T cells at both the population and mechanistic level, and how these effects are modulated by mtDNA variation. We will attain these goals through two study aims that will utilize secondary analysis of existing data and specimens: 1) To identify associations between mtDNA variation and cocaine-induced effects on CD4+ and CD8+ T cell activation and apoptosis in peripheral blood cells from HIV-infected persons; and 2) To identify associations between mtDNA variation and pre- and post-antiretroviral therapy CD4+ T cell levels in HIV-infected cocaine users and non-users. PUBLIC HEALTH RELEVANCE: The goal of the proposed research is to explore the role that variation in human mitochondrial genes may play in the more severe immune dysfunction and faster disease progression seen in HIV-infected persons who use cocaine. Results from these pilot studies will improve our understanding of the relationships between mitochondrial genes, cocaine, and the immune system, and they will inform future clinical trials designed to improve outcomes of HIV-infected persons.
描述(由申请人提供):可卡因是 HIV 感染者中常见的滥用药物,其使用与较差的临床结果独立相关,包括更快的 HIV 疾病进展。除了对心理社会稳定性的间接影响限制了对医疗保健和艾滋病毒治疗的依从性之外,数据还表明可卡因对 CD4+ 和 CD8+ T 细胞功能以及增强艾滋病毒复制的直接影响可能会加速艾滋病毒疾病的发展。可卡因已被证明对多种体外和动物模型系统中的细胞产生不利影响——主要是通过线粒体诱导细胞凋亡途径。鉴于线粒体介导的细胞凋亡在 HIV 感染期间 CD4+ T 细胞耗竭中的主要作用,我们怀疑可卡因对 CD4+ T 细胞和 HIV 疾病进展的不良影响是由线粒体诱导的细胞凋亡介导的,尽管缺乏将可卡因暴露与增强的 CD4+ T 细胞凋亡直接联系起来的数据。线粒体 DNA (mtDNA) 存在于每个线粒体中,编码细胞氧化磷酸化所需的蛋白质亚基,并且是氧化应激、抗氧化能力和诱导细胞损伤响应细胞凋亡的主要介质。线粒体 DNA 单倍群基于​​遗传多态性变异,表示母系血统和人类迁徙,并与退行性和代谢性疾病以及长寿的风险相关。我们的小组投入了大量精力来了解 mtDNA 变异与 HIV 治疗并发症的相关性,其他研究人员最近的一项研究确定了欧洲血统人群中单倍群与 HIV 疾病进展之间的关联。拟议试点研究的目标是通过对可卡因使用在群体和机制水平上对 CD4+ T 细胞的影响以及这些影响如何通过 mtDNA 变异进行调节的新分析,更好地了解药物使用与改变的 HIV 进展和艾滋病发病机制之间的相互作用。我们将通过两个研究目标来实现这些目标,这些目标将利用对现有数据和样本的二次分析:1) 确定 mtDNA 变异与可卡因诱导的对 HIV 感染者外周血细胞 CD4+ 和 CD8+ T 细胞活化和凋亡的影响之间的关联; 2) 确定感染 HIV 的可卡因使用者和非使用者的 mtDNA 变异与抗逆转录病毒治疗前后 CD4+ T 细胞水平之间的关联。 公共健康相关性:拟议研究的目的是探索人类线粒体基因变异在使用可卡因的艾滋病毒感染者中出现的更严重的免疫功能障碍和更快的疾病进展中可能发挥的作用。这些试点研究的结果将增进我们对线粒体基因、可卡因和免疫系统之间关系的理解,并将为未来旨在改善艾滋病毒感染者预后的临床试验提供信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TODD M HULGAN其他文献

TODD M HULGAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TODD M HULGAN', 18)}}的其他基金

Defining the Contribution of Mitochondrial DNA to Viral Infectious Diseases, Type 2 Diabetes, and their Interactions
确定线粒体 DNA 对病毒传染病、2 型糖尿病及其相互作用的作用
  • 批准号:
    10589249
  • 财政年份:
    2023
  • 资助金额:
    $ 15.5万
  • 项目类别:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
神经炎症和手部的铁和线粒体基因组学:一项宪章研究
  • 批准号:
    8294542
  • 财政年份:
    2011
  • 资助金额:
    $ 15.5万
  • 项目类别:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
神经炎症和手部的铁和线粒体基因组学:一项宪章研究
  • 批准号:
    8845250
  • 财政年份:
    2011
  • 资助金额:
    $ 15.5万
  • 项目类别:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
神经炎症和手部的铁和线粒体基因组学:一项宪章研究
  • 批准号:
    8458599
  • 财政年份:
    2011
  • 资助金额:
    $ 15.5万
  • 项目类别:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
神经炎症和手部的铁和线粒体基因组学:一项宪章研究
  • 批准号:
    8896116
  • 财政年份:
    2011
  • 资助金额:
    $ 15.5万
  • 项目类别:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
神经炎症和手部的铁和线粒体基因组学:一项宪章研究
  • 批准号:
    8658731
  • 财政年份:
    2011
  • 资助金额:
    $ 15.5万
  • 项目类别:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
神经炎症和手部的铁和线粒体基因组学:一项宪章研究
  • 批准号:
    8210312
  • 财政年份:
    2011
  • 资助金额:
    $ 15.5万
  • 项目类别:
Mitochondrial Genomics and Effects of Cocaine on T cells during HIV-Infection
HIV 感染期间线粒体基因组学和可卡因对 T 细胞的影响
  • 批准号:
    8112582
  • 财政年份:
    2010
  • 资助金额:
    $ 15.5万
  • 项目类别:
Mitochondrial Genomics and Peripheral Neuropathy during HIV Therapy
HIV 治疗期间的线粒体基因组学和周围神经病变
  • 批准号:
    7284699
  • 财政年份:
    2007
  • 资助金额:
    $ 15.5万
  • 项目类别:
Mitochondrial Genomics and Peripheral Neuropathy during HIV Therapy
HIV 治疗期间的线粒体基因组学和周围神经病变
  • 批准号:
    7383762
  • 财政年份:
    2007
  • 资助金额:
    $ 15.5万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 15.5万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 15.5万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 15.5万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 15.5万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 15.5万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 15.5万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 15.5万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 15.5万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 15.5万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 15.5万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了